18 hasil untuk "Zeba Aziz"
Menampilkan 1–18 · 0,65 detik · RSS
-
Artikel Jurnal
Challenges in Access to New Therapeutic Agents: Marginalized Patients With Cancer in Pakistan and the Need for New Guidelines
PURPOSECancer care disparities persist among the medically underserved patients with cancer in Pakistan. To determine the access that marginalized patients with cancer have to chemotherapy and newer targeted agents in Pakistan approved by essential medicine list 2017, the barriers that patients…
-
Artikel Jurnal
OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN OLDER ADULTS TREATED IN RESOURCE-CONSTRAINED SETTINGS
Objective: Treating Diffuse Large B-Cell Lymphoma (DLBCL) in elderly patients is challenging. There is limited data available from Low- and Middle-Income Countries (LMICs) on elderly DLBCL. We analyzed the presentations and survival outcomes of patients with DLBCL according to their socioeconomic…
-
Artikel Jurnal
Modelling the potential financial impacts of expanding access to immune checkpoint inhibitors as monotherapy for treating advanced non-small cell lung cancerResearch in context
Summary: Background: Access to immune checkpoint inhibitors remains limited due to cost-effectiveness and affordability concerns. This study evaluates the financial impacts of expanding global access to PD1/PD-L1 inhibitors as first-line monotherapy for patients aged 40–74 years with advanced…
-
Artikel Jurnal
Impact of resource availability on outcomes of diffuse large B-cell lymphoma: real-world data from Pakistan
Abstract: The purpose of this study is to assess the impact of resource availability on the outcomes of diffuse large B-cell lymphoma (DLBCL) and identify areas of improvement in managing DLBCL in resource-limited settings. This multicentric retrospective study included 756 patients across 12…
-
Artikel Jurnal Teks lengkap
“Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan”
Purpose: COVID-19 infection resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began to spread across the globe in early 2020. Patients with hematologic malignancies are supposed to have an increased risk of mortality from coronavirus disease of 2019 (COVID-19) infection…
-
Artikel Jurnal
Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country
PURPOSETo highlight challenges and cancer care disparities in patients of diffuse large B-cell lymphoma management in resource-constrained settings.MATERIALS AND METHODSThis multicenter retrospective study included 738 patients from 12 public and private sector hematology-oncology centers across…
-
Artikel Jurnal
Geriatric Assessment: ASCO Global Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual, ASCO Guidelines follow the ASCO Conflict of Interest Policy for…
-
Artikel Jurnal
Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline
PURPOSETo provide expert guidance to clinicians and policymakers in three resource-constrained settings on diagnosis and staging of adult women with ovarian masses and treatment of patients with epithelial ovarian (including fallopian tube and primary peritoneal) cancer.METHODSA multidisciplinary…
-
Artikel Jurnal
Diagnosis and Management of Diffuse Large B-Cell Lymphoma: Society of Medical Oncology, Pakistan Society of Hematology, and Pakistan Society of Clinical Oncology Joint Clinical Practice Guideline
Diffuse large B-cell lymphoma (DLBCL) is the commonest non-Hodgkin lymphoma encountered by hematopathologists and oncologists. Management guidelines for DLBCL are developed and published by countries with high income and do not cater for practical challenges faced in resource-constrained settings…
-
Artikel Jurnal
Clinical practice guidelines for the diagnosis and management of Hodgkin lymphoma in countries with restricted resources
Background: Classical Hodgkin lymphoma (cHL) is a highly curable malignancy but presents a significant health challenge in low- to middle-income countries (LMICs), where resource constraints, lack of novel therapies, and advanced diagnostics hinder effective treatments, particularly in relapsed…
-
Artikel Jurnal
World health Organization’s guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoringResearch in context
Summary: Background: Non-communicable diseases (NCDs) account for over 60% of annual global deaths, disproportionately affecting low- and middle-income countries. This trend undermines progress toward Sustainable Development Goal (SDG) 3.4, which seeks to reduce premature mortality from NCDs by…